Jeffrey Brian McGroarty

Jeffrey Brian McGroarty discloses dealings in Annovis Bio, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 31 January 2020 and the latest from 3 February 2020.

No open-market sale appears; the market trades are 3 purchases worth €307k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €125k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -40.4%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 5 February 2020 with an open-market purchase (€125k) in Annovis Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.